Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000499683 | SCV000595490 | uncertain significance | not specified | 2016-03-25 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002524214 | SCV002966900 | uncertain significance | L-2-hydroxyglutaric aciduria | 2022-07-01 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 160 of the L2HGDH protein (p.Gly160Asp). This variant is present in population databases (rs761645660, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with L2HGDH-related conditions. ClinVar contains an entry for this variant (Variation ID: 435696). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |